BIOPHARM ASIA INC | 0,044 Euro | -0,001 -2,22 % | |
| WKN: A1CU18 ISIN: US09071E1047 Ticker-Symbol: BYP | Stuttgart | 25.05.12 | 08:08 Uhr |
Branche PharmaAktienmarkt ASIEN |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 06.04. | BioPharm Asia, Inc. (PINK:BFAR) Surging on Promises | 9 | HotStocked.com | |
| 03.04. | Biopharm Asia Announces Status of Restatement of Financial Reports and Its Intention to File Form 10 to Commence Filing SEC Reports | 19 | MarketWire | |
| NEW YORK, NY and TONGHUA, CHINA -- (Marketwire) -- 04/03/12 -- Biopharm Asia, Inc. (PINKSHEETS: BFAR) announced a status update regarding restated financial results of 2008, 2009 and 2010. As the... Mehr lesen zu: Biopharm Asia Announces Status of Restatement of Financial Reports and Its Intention to File Form 10 to Commence Filing SEC Reports | ||||
| 26.01. | BioPharm Asia Acquires Specialty Hospital in Fujian | 59 | MarketWire | |
| NEW YORK, NY and TONGHUA, CHINA -- (Marketwire) -- 01/26/12 -- BioPharm Asia, Inc. (PINKSHEETS: BFAR) (the "Company") announced today that the company entered into an agreement to acquire Xiamen Tongji... Mehr lesen zu: BioPharm Asia Acquires Specialty Hospital in Fujian | ||||
| 19.12. | BioPharm Asia Announces Hospital Management Contract / BioPharm Asia Is Engaged as Master Consultant for New Hospital in BEIJING | 46 | MarketWire | |
| NEW YORK, NY and TONGHUA, CHINA -- (Marketwire) -- 12/19/11 -- BioPharm Asia (PINKSHEETS: BFAR) and Elite Capital Group announced today the signing of a consulting agreement for the development of... Mehr lesen zu: BioPharm Asia Announces Hospital Management Contract / BioPharm Asia Is Engaged as Master Consultant for New Hospital in BEIJING | ||||
| 08.12. | BioPharm Asia Appoints Independent Director | 44 | MarketWire | |
| NEW YORK, NY and TONGHUA, CHINA -- (Marketwire) -- 12/08/11 -- BioPharm Asia, Inc. (PINKSHEETS: BFAR), a producer, distributor and retailer of medical products in China, today announced appointment... Mehr lesen zu: BioPharm Asia Appoints Independent Director | ||||
| 05.12. | BioPharm Asia Announces Preliminary Unaudited Third Quarter 2011 Results / Revenue Increases 5.6% to $47.2 Million; Net Income Up 6% to $6.9 Million | 67 | MarketWire | |
| NEW YORK, NY and TONGHUA, CHINA -- (Marketwire) -- 12/05/11 -- BioPharm Asia, Inc. (OTCBB: BFAR), a producer, distributor and retailer of medical products in China, today announced its financial results... Mehr lesen zu: BioPharm Asia Announces Preliminary Unaudited Third Quarter 2011 Results / Revenue Increases 5.6% to $47.2 Million; Net Income Up 6% to $6.9 Million | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| MERCK KGAA | 75,00 | +0,23 % | ANALYSE-FLASH: Commerzbank hebt Ziel für Merck KGaA auf 81 Euro - 'Hold' |
| STADA ARZNEIMITTEL AG | 24,840 | -0,64 % | Kepler hebt Ziel für Stada auf 32 Euro - 'Buy' |
| GERRESHEIMER AG | 35,215 | +1,63 % | DGAP-Stimmrechte: Gerresheimer AG (deutsch) |
| CELESIO AG | 11,750 | +0,30 % | Celesio AG: Neues 13-Wochentief (11.71 Euro, Short) |
| ROCHE HOLDING AG GS | 126,55 | -1,33 % | WestLB belässt Roche auf 'Neutral' |
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage